Knorex Ltd Stock Performance

KNRX Stock   2.08  0.02  0.95%   
The company secures a Beta (Market Risk) of 1.47, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, KNOREX will likely underperform. At this point, KNOREX LTD has a negative expected return of -1.65%. Please make sure to verify KNOREX's jensen alpha, kurtosis, as well as the relationship between the Kurtosis and price action indicator , to decide if KNOREX LTD performance from the past will be repeated at future time.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days KNOREX LTD has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in November 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more

Actual Historical Performance (%)

One Day Return
(0.72)
Five Day Return
13.04
Year To Date Return
(35.00)
Ten Year Return
(35.00)
All Time Return
(35.00)
1
Knorex prices 12 million IPO at 4 per share - Investing.com
09/29/2025
2
Knorex Ltd Announces Closing of 12 Million Initial Public Offering
10/01/2025
3
KNOREX CEO Provides Shareholder Letter Highlighting Recent NYSE American Listing and Strategic Business Outlook
10/09/2025
4
KNOREX Announces Strategic Partnership with Leading B2B Data Provider to Enhance Data-Driven Marketing Capabilities
10/15/2025

KNOREX Relative Risk vs. Return Landscape

If you would invest  320.00  in KNOREX LTD on August 1, 2025 and sell it today you would lose (112.00) from holding KNOREX LTD or give up 35.0% of portfolio value over 90 days. KNOREX LTD is currently does not generate positive expected returns and assumes 6.5518% risk (volatility on return distribution) over the 90 days horizon. In different words, 58% of stocks are less volatile than KNOREX, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days KNOREX is expected to under-perform the market. In addition to that, the company is 10.56 times more volatile than its market benchmark. It trades about -0.25 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.23 per unit of volatility.

KNOREX Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for KNOREX's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as KNOREX LTD, and traders can use it to determine the average amount a KNOREX's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.252

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsKNRX

Estimated Market Risk

 6.55
  actual daily
58
58% of assets are less volatile

Expected Return

 -1.65
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.25
  actual daily
0
Most of other assets perform better
Based on monthly moving average KNOREX is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of KNOREX by adding KNOREX to a well-diversified portfolio.

KNOREX Fundamentals Growth

KNOREX Stock prices reflect investors' perceptions of the future prospects and financial health of KNOREX, and KNOREX fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on KNOREX Stock performance.

About KNOREX Performance

Evaluating KNOREX's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if KNOREX has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if KNOREX has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.42)(1.49)
Return On Capital Employed 1.36  1.42 
Return On Assets(1.08)(1.14)
Return On Equity 1.35  1.42 

Things to note about KNOREX LTD performance evaluation

Checking the ongoing alerts about KNOREX for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for KNOREX LTD help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
KNOREX LTD generated a negative expected return over the last 90 days
KNOREX LTD has high historical volatility and very poor performance
KNOREX LTD has a very high chance of going through financial distress in the upcoming years
KNOREX LTD has a frail financial position based on the latest SEC disclosures
Latest headline from globenewswire.com: KNOREX Announces Strategic Partnership with Leading B2B Data Provider to Enhance Data-Driven Marketing Capabilities
Evaluating KNOREX's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate KNOREX's stock performance include:
  • Analyzing KNOREX's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether KNOREX's stock is overvalued or undervalued compared to its peers.
  • Examining KNOREX's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating KNOREX's management team can have a significant impact on its success or failure. Reviewing the track record and experience of KNOREX's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of KNOREX's stock. These opinions can provide insight into KNOREX's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating KNOREX's stock performance is not an exact science, and many factors can impact KNOREX's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for KNOREX Stock Analysis

When running KNOREX's price analysis, check to measure KNOREX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy KNOREX is operating at the current time. Most of KNOREX's value examination focuses on studying past and present price action to predict the probability of KNOREX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move KNOREX's price. Additionally, you may evaluate how the addition of KNOREX to your portfolios can decrease your overall portfolio volatility.